...
首页> 外文期刊>Pakistan Heart Journal >Treatment of Dyslipidemia with Gemfibrozii A Pilot Study in Pakistan
【24h】

Treatment of Dyslipidemia with Gemfibrozii A Pilot Study in Pakistan

机译:吉非贝齐治疗血脂异常的巴基斯坦一项初步研究

获取原文
           

摘要

Material and Methods: Cases were selected from patients referred to the Investigator from the Outpatient Department of the NICVD Karachi during the study period. These patients had a lipid profile done and found to have dyslipidemia. All values are expressed as mean with a single standard deviation. Chi Square analysis and Student T test are used for group comparison. Statistically significant means a p value 270 mg% and! or Triglycerides > 200mg%. 16 of these 26 subjects were randomized to 8 weeks of drug treatment and 10 subjects to placebo treatment. 8 subjects in the drug treatment group and 8 subjects in the placebo treatment group complete d the entire protocol.Of the 65 male subjects initially referred to the Investigator, only 26 were found to fulfill all the recruitment criteria, and, 16 were random ized to the drug treatment group and 10 to the placebo group. DISCUSION: In the last few years a significant change has occurred in our thinking as to the definition of what consititures a ‘normal’ lipid profile and presently it is generally stated that the ideal total cholesterol value ought to be below 200mg%, LDL-Cholesterol below 160 mg% and that the HDL-Cholesterol to be 20% or more of the total cholesterol value (10,11).The greater was the lipid normalizing effect of Gemfibrozil, thereby reducing coronary risk in these dyslipdemic Pakistani subjects.
机译:材料和方法:在研究期间从NICVD卡拉奇门诊部转介给研究人员的患者中选择病例。这些患者的血脂状况良好,发现血脂异常。所有值均表示为平均值,只有一个标准偏差。卡方分析和学生T检验用于组比较。统计显著性是指p值为270 mg%和!或甘油三酸酯> 200mg%。这26名受试者中的16名被随机分配到药物治疗8周,而10名受试者接受安慰剂治疗。药物治疗组中的8名受试者和安慰剂治疗组中的8名受试者完成了整个方案。最初转介给研究人员的65名男性受试者中,只有26名符合所有募集标准,并且有16名被随机分为药物治疗组和安慰剂组10个。讨论:在过去的几年中,我们对什么构成“正常”脂质分布的定义发生了重大变化,目前一般认为理想的总胆固醇值应低于200mg%,LDL-胆固醇低于160 mg%且HDL胆固醇占总胆固醇值的20%或更高(10,11)。吉非贝齐的脂质正常化作用更大,从而降低了这些血脂异常巴基斯坦受试者的冠心病风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号